3 min read
Highlights
Singapore and Italy show that a national longevity strategy is moving from an idea into a serious public policy priority.
- Singapore is designing a longevity society: Its SGD 350 million Healthy Longevity Grand Challenge and Age Well SG demonstrate a coordinated focus on prevention, independence and longer healthy lives.
- Italy is proposing a measured health-system response: Its roadmap would test biomarkers, digital monitoring, interventions and AI against clinical utility, safety, equity and cost-effectiveness.
- The lifespan–healthspan gap is now impossible to ignore: Living longer has limited value if additional years are marked by frailty, loss of independence or poor quality of life.
- Food and beverage leaders are part of the solution: Nutrition, functional foods, genomics, microbiome science and AI will increasingly connect food systems with national health outcomes.
A national longevity strategy is becoming one of the defining policy challenges of the twenty-first century. Singapore has shown how governments can move beyond managing an ageing population and begin designing a society where people remain healthier, independent and economically active for longer.
Not all technologies fit neatly into the TECHXponential™ model, but some are too innovative to pass up on reporting.
Longevity now sits at the intersection of biology, technology, food, healthcare and public policy.
From Singapore to Italy
In my earlier article, Singapore’s move from an ageing population to a longevity society, I explored the country’s SGD 350 million Healthy Longevity Grand Challenge and its Age Well SG programme.
These initiatives show that Singapore isn’t treating longevity as a private wellness trend. It’s approaching healthy ageing as national infrastructure. Research, healthcare, housing, community design and workforce policy are being connected around a common goal. That includes capability building through the NUS Medicine Clinical Trial Centre and translational research through PROMETHEUS.
Italy is now adding another important signal.
A recent article from Longevity.Technology discusses a proposal to make healthspan a measurable objective within Italy’s National Health Service. The proposal is supported by a research perspective published in Aging.
Italy reportedly has one of the oldest populations in the world, with people aged 65 and over representing 24.1% of the population. The source article reports a gap between lifespan and healthy life years of 15.8 years for women and 12.9 years for men.
That gap doesn’t mean people live all those years with a diagnosed disease. It’s a broader measure of the difference between being alive and remaining in good health, with physical and cognitive function intact.
The question for governments is becoming clear. How do we make sure that longer lives are also better lives?
Evidence before excitement
Italy’s proposal is important because it isn’t calling for every citizen to receive an ageing clock, an experimental drug or an AI-generated health score tomorrow.
Instead, it recommends a staged approach. Biomarkers, digital monitoring, nutrition, physical activity programmes and AI tools would need to prove their clinical usefulness, safety, feasibility, equity and cost-effectiveness before becoming part of routine care.
That’s exactly the discipline this field needs.
Biological plausibility isn’t enough. A technology might sound impressive in a laboratory yet fail to improve independence, reduce hospitalisation or deliver better care. Public health systems must ask a harder question. Does this intervention improve outcomes that matter to people and communities?
This is where organisations such as the AEON Foundation are helping to move the conversation forward. AEON isn’t a government body and it hasn’t implemented national policy. Its role is to help translate longevity research into evidence-based policies that could extend life and improve quality of life, while bringing researchers, industry and institutions into the same discussion.
The Milan Longevity Summit reflects this wider ambition. Its One Health approach connects human health with food, cities, the environment, technology, finance and society.

Why food belongs in the healthspan conversation
For food and beverage leaders, this shift has major implications.
As governments move from treating disease late, to preventing decline earlier, food becomes part of the healthspan infrastructure. That doesn’t mean every product should make a longevity claim. It means the industry will face stronger expectations around nutrition, evidence, transparency and measurable benefit.
Five technology areas will increasingly work together.
- Alternative proteins could help create healthier, more sustainable sources of nutrition for an ageing global population.
- Cellular agriculture may enable new ways to produce specific ingredients with greater control over consistency and resource use.
- Genomics could improve understanding of how individuals respond differently to nutrients.
- Microbiome research may reveal more about the relationship between diet, gut ecosystems and health.
- Synthetic biology could help design new ingredients and production systems with targeted functions.
None of these technologies is a complete answer on its own. Their value will come from how they connect with sensors, clinical research, digital records and AI tools that help people and professionals understand what works.
That is the central idea behind my keynote, “Longevity and Aging 2.0 When AI, Food and Aging Converge”. The future won’t be created by one breakthrough. It will emerge from the integration of many systems.

A national priority with a human purpose
Singapore and Italy are approaching the issue differently. Singapore is building a coordinated longevity society through research, prevention and community design. Italy is considering how a universal health service could introduce longevity medicine carefully, with evidence and equity at its core.
Both approaches point in the same direction.
Ageing is no longer only a personal issue. It affects healthcare budgets, workforce participation, food systems, urban planning, pensions and social cohesion. As more countries face similar demographic pressures, managing ageing will become a national priority. For Boards and executives, a national longevity strategy is becoming a test of long-term resilience.
I believe the most successful nations won’t simply ask how to keep people alive for longer. They’ll ask how to preserve independence, contribution, purpose and quality of life across those additional years.
The future formula is simple.
Longer lives + better prevention + evidence-based innovation = healthier societies
To continue the conversation email me at tony@tonyhunterspeaker.com
